Meta-analysis: Pharmacologic Treatment of Restricted and Repetitive Behaviors in Autism Spectrum Disorders
- 6 May 2020
- journal article
- review article
- Published by Elsevier BV in Journal of the American Academy of Child & Adolescent Psychiatry
- Vol. 60 (1), 35-45
- https://doi.org/10.1016/j.jaac.2020.03.007
Abstract
No abstract availableKeywords
Funding Information
- Yale School of Medicine
This publication has 83 references indexed in Scilit:
- A randomised controlled trial of bumetanide in the treatment of autism in childrenTranslational Psychiatry, 2012
- Placebo-Controlled Pilot Trial of Mecamylamine for Treatment of Autism Spectrum DisordersJournal of Child and Adolescent Psychopharmacology, 2012
- Pharmacologic Treatment of Repetitive Behaviors in Autism Spectrum Disorders: Evidence of Publication BiasPEDIATRICS, 2012
- Effects of Large Doses of Arachidonic Acid Added to Docosahexaenoic Acid on Social Impairment in Individuals With Autism Spectrum DisordersJournal of Clinical Psychopharmacology, 2012
- Intranasal oxytocin versus placebo in the treatment of adults with autism spectrum disorders: a randomized controlled trialMolecular Autism, 2012
- A Pilot Randomized Controlled Trial of Omega-3 Fatty Acids for Autism Spectrum DisorderJournal of Autism and Developmental Disorders, 2010
- Cardiometabolic Risk of Second-Generation Antipsychotic Medications During First-Time Use in Children and AdolescentsJAMA, 2009
- Randomized, Placebo-Controlled, Crossover Study of Methylphenidate for Attention-Deficit/Hyperactivity Disorder Symptoms in Preschoolers with Developmental DisordersJournal of Child and Adolescent Psychopharmacology, 2009
- A Placebo Controlled Crossover Trial of Liquid Fluoxetine on Repetitive Behaviors in Childhood and Adolescent AutismNeuropsychopharmacology, 2004
- Lack of Benefit of a Single Dose of Synthetic Human Secretin in the Treatment of Autism and Pervasive Developmental DisorderThe New England Journal of Medicine, 1999